Dr. Yoo is deeply passionate about promoting sun safety and skin protection. With a commitment to raising awareness about the importance of sunscreen, she strives to empower individuals to make informed choices for their skin health. Her advocacy work reflects her belief that everyone deserves access to effective sun protection, and she is dedicated to fostering a culture of awareness and prevention in the community.
Advocating to Congress at Capitol Hill
In June 2024, Dr. Jane Yoo spoke at Capitol Hill during the 3rd Annual Safer Under the Sun Day, hosted by DSM-Firmenich Beauty & Care. This event brought together medical professionals, policymakers, and industry leaders to address the urgent need for advanced sunscreen innovations in the fight against skin cancer. Dr. Yoo emphasized the importance of collaboration between the industry and government to streamline regulatory processes and make new over-the-counter (OTC) sunscreen drugs more accessible to Americans. With skin cancer cases rising and the U.S. lagging behind in adopting new sunscreen filters, her advocacy underscored the necessity of promoting innovative, broad-spectrum sun protection options for all Americans.
Photobiology Committee
As a member of the Skin Cancer Foundation’s Photobiology Committee, Dr. Jane Yoo plays a pivotal role in granting the Foundation’s Seal of Recommendation to sunscreens and UV-protective products. This trusted seal, recognized globally, signifies that products meet rigorous standards for effective sun protection. Dr. Yoo and fellow experts carefully review scientific data submitted by manufacturers, ensuring that only products with proven safety and efficacy receive this prestigious designation. Her work supports the Foundation’s mission to provide consumers with reliable options for protecting their skin from harmful ultraviolet radiation.
Lobbying for the SAFE Sunscreen Standards Act with PCPC
In May 2026, Dr. Yoo returned to Capitol Hill, this time invited by the Personal Care Products Council (PCPC) to lobby Congress in support of ensuring the FDA fully implements the provisions of the SAFE Sunscreen Standards Act, included in the reauthorization of the Over-the-Counter Monograph Drug User Fee Amendments (OMUFA).
Skin cancer is the most common cancer in the United States, more people are diagnosed with it each year than all other cancers combined, with nearly five million Americans treated annually at a cost exceeding $8.1 billion. And yet, the FDA has not approved a new UV filter since 1999. While patients in Korea, Japan, and Europe have had access to safer, more photostable UV filters for decades, American consumers have been left behind.
Last year, Congress took a meaningful step forward: OMUFA reauthorization included language allowing the FDA to use a wider variety of evidence when evaluating new UV filters. The House Appropriations Committee’s FY2027 FDA budget now includes report language directing the FDA to expeditiously finalize its proposed order. Dr. Yoo was on the Hill to make sure that language stays in the bill.
Across eight meetings in four congressional office buildings, Dr. Yoo met with staff from the offices of Senators Schiff, Murray, Kim, and Moody, and Representatives Kamlager, Scholten, Levin, and Kean.